Faron Pharmaceuticals Oy
AIM:FARN
£ 2.40
+ £0.15 (6.67%)
£ 2.40
+ £0.15 (6.67%)
End-of-day quote: 05/15/2024

Faron Pharmaceuticals Oy financials at a glance

The revenue of Faron Pharmaceuticals Oy is reported as 0 billion Pounds in the fiscal year 2023. The earnings were -0.52 Pounds per share in 2023, which was 23.81 lower than 2021. And about -0.023 billion Pounds are reported as free cash flow in the financials of Faron Pharmaceuticals Oy 2023. No dividends were paid to the shareholders of the Faron Pharmaceuticals Oy stock AIM:FARN in the financial year 2023.

£0.00M
Revenue
£-0.52
Earnings Per Share
0.00%
Gross Margin %
£-23.38M
Free Cash Flow
Revenue
0.00
Earnings Per Share
-0.52
Gross Margin %
0.00
Free Cash Flow
-23.38

Financials

Year Year TTM 2022 2021 2020 2019 2018 2017 2016 2015
Rev. Revenue N/A £0.00M £0.00M £0.00M £0.00M £0.02M £0.00M £1.15M £0.00M
GM % Gross Margin % 0.00% 0.00% 0.00% 100.00% 0.00% 100.00% 100.00% 100.00% 95.19%
OM Operating Margin 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Earnings Per Share £-0.49 £-0.52 £-0.42 £-0.37 £-0.31 £-0.65 £-0.76 £-0.39 £-0.30
Div. Dividends N/A £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00 £0.00
PR % Payout Ratio % 0 -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0
Sha. Shares N/AM 59.81M 53.23M 46.9M 43.29M 35.48M 29.16M 26.31M 23.11M
OCF Operating Cash Flow N/A £-22.99M £-22.22M £-17.48M £-11.52M £0.00M £-18.36M £0.00M £0.00M
FCF Free Cash Flow N/A £-23.38M £-22.23M £-17.49M £0.00M £0.00M £-18.37M £0.00M £0.00M
FCFS Free Cash Flow Per Share £-0.40 £-0.42 £-0.45 £-0.39 £-0.33 £-0.68 £-0.66 £-0.40 £-0.35